Skip to main content
Updating results

Alzheimer's Disease

  • Updated

WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

Marlin Richard Hensel passed away peacefully at home in Mechanicsburg, Pennsylvania, on February 26, 2021 after a seven-year bout with Alzheim…

  • Updated

For each state, prevalence and cost statistics for 2017 (the most recent year available) are from the Centers for Medicare and Medicaid Services (CMS). The data is for individuals aged 65 and over with Alzheimer’s disease, senile dementia, or related disorders.

Get up-to-the-minute news sent straight to your device.


News Alerts

Breaking News